PROMETHEUS BIOSCIENCES INC's ticker is RXDX and the CUSIP is 74349U108. A total of 119 filers reported holding PROMETHEUS BIOSCIENCES INC in Q2 2022. The put-call ratio across all filers is 10.24 and the average weighting 1.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $16,577,292 | -12.0% | 154,466 | -9.8% | 5.40% | -17.3% |
| Q4 2022 | $18,829,910 | +65.3% | 171,181 | -11.3% | 6.53% | +31.4% |
| Q3 2022 | $11,394,000 | +164.4% | 193,075 | +26.5% | 4.96% | +153.8% |
| Q2 2022 | $4,310,000 | -50.6% | 152,665 | -35.2% | 1.96% | -61.9% |
| Q1 2022 | $8,725,000 | +44.5% | 235,756 | +54.4% | 5.13% | +23.8% |
| Q4 2021 | $6,036,000 | – | 152,665 | – | 4.14% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| 72 Investment Holdings, LLC | 1,848,024 | $203,282,640 | 93.46% |
| CHI Advisors LLC | 923,800 | $101,618,000 | 27.06% |
| Sio Capital Management, LLC | 574,200 | $63,162,000 | 23.36% |
| Cormorant Asset Management, LP | 2,090,000 | $229,900 | 15.38% |
| Boxer Capital, LLC | 1,897,500 | $208,725,000 | 11.00% |
| SEVEN GRAND MANAGERS, LLC | 20,105 | $2,211,550 | 10.34% |
| Decheng Capital Management III (Cayman), LLC | 250,000 | $27,500,000 | 10.29% |
| Ikarian Capital, LLC | 288,926 | $31,781,860 | 7.67% |
| RTW INVESTMENTS, LP | 3,354,303 | $368,973,330 | 7.53% |
| Waypoint Capital Advisors, LLC | 171,181 | $18,829,910 | 6.53% |